Insider Transactions in Q1 2024 at Cerence Inc. (CRNC)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 22
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,389
-2.79%
|
$215,446
$14.82 P/Share
|
Mar 21
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,000
-1.9%
|
$70,000
$14.99 P/Share
|
Mar 18
2024
|
Daniel David Tempesta CFO |
BUY
Grant, award, or other acquisition
|
Direct |
307,797
+45.0%
|
$0
$0.01 P/Share
|
Mar 14
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
21,446
-3.74%
|
$300,244
$14.73 P/Share
|
Feb 15
2024
|
Thomas L Beaudoin |
BUY
Grant, award, or other acquisition
|
Direct |
1,005
+0.38%
|
$13,065
$13.58 P/Share
|
Feb 15
2024
|
Marcy S Klevorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+36.57%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Alfred A Nietzel Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+18.25%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Kristi Ann Matus Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+18.45%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Sanjay K Jha Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+16.19%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Marianne Budnik Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+16.19%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Douglas Lee Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+30.21%
|
$0
$0.01 P/Share
|
Feb 15
2024
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,196
+11.85%
|
$0
$0.01 P/Share
|
Jan 12
2024
|
Stefan Ortmanns Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,942
-2.04%
|
$226,898
$19.26 P/Share
|
Jan 09
2024
|
Thomas L Beaudoin |
SELL
Open market or private sale
|
Direct |
5,185
-1.94%
|
$93,330
$18.79 P/Share
|
Jan 09
2024
|
Iqbal Arshad EVP, CTO |
SELL
Open market or private sale
|
Direct |
5,188
-2.13%
|
$93,384
$18.79 P/Share
|